Navigation Links
Use of high hydrostatic pressure to inactivate Hepatitis A virus in oysters studied

NOAA/Virginia Sea Grant has awarded Virginia Tech $119,000 to study whether high hydrostatic pressure will inactivate Hepatitis A virus in both shucked and unshucked oysters.

The project, led by Daniel Holliman, an M.D. with the High Pressure Processing Laboratory, and Laura Douglas, lab manager, will identify one or more effective high pressure processing schedules. The laboratory is a facility of the Department of Food Science and Technology at Virginia Tech, devoted to improving food safety and food processing.

Hepatitis A virus (HAV) is one of the more serious illnesses transmissible by shellfish. Worldwide, HAV is responsible for more than 1.5 million cases of the disease each year, with 260,000 cases and more than 100 deaths in the United States. Hepatitis A infection is characterized by fatigue, malaise, fever, loss of appetite, nausea, vomiting, joint and muscle aches, and abdominal pain, coupled with the onset of jaundice, a yellowing of the whites of the eyes, and dark urine. The disease generally runs its course in two months, but can linger as long as six. While survival rates for Hepatitis A are above 99 percent, the disease can be very dangerous for infants, the elderly, immunosuppressed people, and those with existing liver disease.

Bivalve shellfish, such as oysters, have been demonstrated to concentrate pathogenic organisms from their environment. In some cases, sewage contamination of harvesting areas, either from coastal runoff or ship discharges, has been shown to result in HAV contamination of oysters. Several studies have demonstrated remarkable concentration and persistence of HAV in shellfish exposed to the virus through their surrounding seawater. Even with depuration, HAV may persist in oysters for several weeks after exposure. The virus also is fairly resistant to heating and may remain viable in shellfish after up to five minutes of steaming.

For these reasons, high hydrostatic pressure treatment of raw oyst ers is especially appealing to oyster processors and distributors, as well as public health officials. HPP makes it possible to eradicate or inactivate pathogens while still delivering a 'raw' product to the consumer.

The study will benefit processors and distributors by mitigating their food safety liability, but most importantly, also will help protect consumers from foodborne infectious disease.

Virginia Sea Grant is part of a 30-state National Sea Grant Program established by Congress in 1966 as part of the National Oceanic and Atmospheric Administration. Sea-grant colleges research new ideas and technologies to help use, manage, and understand ocean and coastal resources. Virginia Sea Grant funds marine science research in aquaculture, seafood safety and quality, marine resources, coastal ecosystems through a competitive, peer-reviewed grant proposal process. In addition to its core programs, Virginia Sea Grant coordinates research in oyster disease and toxics in the Chesapeake Bay.


'"/>

Source:Virginia Tech


Related biology news :

1. Gene therapy to lower blood pressure just enough
2. Researchers learn how blood vessel cells cope with their pressure-packed job
3. Genes affecting blood pressure change as children become adults
4. How nice, brown rice: Study shows rice bran lowers blood pressure in rats
5. Blame the brain for high blood pressure
6. Its OK for men with high blood pressure to have a drink or two, new study finds
7. 8 plants from South Africa may hold potential for treating high blood pressure
8. Scientists Replicate Hepatitis C Virus in Laboratory
9. Norovirus, AIDS vaccine and Hepatitis Virus
10. UCLA study assesses cost-effectiveness of Hepatitis B drugs
11. Natural Killers Could Lead to New Hepatitis Treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2018)... ... August 25, 2018 , ... Maire ... a biofield energy treated nutraceutical to reduce inflammation and autoimmune disorders and improve ... blood, as well as inflammation. The following data was reported:, ...
(Date:8/23/2018)... ... August 22, 2018 , ... ... LimitLIS® 4.0, the latest version of its rapidly growing cloud-based laboratory information system. ... Edition, as well as the company’s triple digit growth throughout 2018, the RURO ...
(Date:8/21/2018)... ... August 20, 2018 , ... Genedata, ... that Seattle-based Aptevo Therapeutics , a clinical-stage biotechnology company, has adopted ... Genedata Biologics ® platform to facilitate expansion of their pipeline of novel ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD, announced ... Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined the firm as ... Systems at WellDoc, Inc., she conducted quality control and supplier audits, led inspections ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced it ... as an executive and leader of numerous biotech companies. , He most recently ... company acquired by Thompson Street Capital in St. Louis, MO. Prior to ISTO, ...
(Date:8/29/2018)... ... August 28, 2018 , ... Cognition Corporation ®, a software ... talks for NAVIGATE2018 . , Ryan Ward, Director of Engineering at Zimmer ... conference. An experienced engineer and manager with Zimmer Biomet for almost 15 years, Mr. ...
(Date:8/26/2018)... ... August 23, 2018 , ... LabRoots ... scientists from around the world, will host the 4th Annual Microbiology and Immunology ... industries and disciplines, encompassing various research areas including medicine, agriculture, and space. ...
Breaking Biology Technology: